Thye Dirk's most recent trade in Quince Therapeutics Inc was a trade of 150,944 Warrants done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quince Therapeutics Inc | Dirk Thye | Director, CEO and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 150,944 | 150,944 | - | - | Warrants | |
| Quince Therapeutics Inc | Dirk Thye | Director, CEO and CMO | Grant, award, or other acquisition of securities at price $ 1.20 per share. | 18 Jun 2025 | 150,944 | 994,885 (3%) | 0% | 1.2 | 181,133 | Common Shares |
| Quince Therapeutics Inc | Dirk Thye | Director, CEO AND CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 1,200,000 | 1,200,000 | - | - | Employee Stock Option (right to buy) | |
| Quince Therapeutics Inc | Dirk Thye | Director, CEO AND CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 29 Aug 2024 | 77,500 | 766,941 (2%) | 0% | 0.7 | 53,475 | Common Stock |
| Quince Therapeutics Inc | Dirk Thye | Director, CEO AND CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 29 Aug 2024 | 77,000 | 843,941 (2%) | 0% | 0.7 | 53,900 | Common Stock |
| Quince Therapeutics Inc | Dirk Thye | Director, CEO AND CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 1,500,000 | 1,500,000 | - | - | Employee Stock Option (right to buy) | |
| Quince Therapeutics Inc | Dirk Thye | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 149,999 | 450,001 | - | - | Employee Stock Option (right to buy) | |
| Quince Therapeutics Inc | Thye Dirk | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.94 per share. | 16 Jan 2024 | 149,999 | 689,441 (2%) | 0% | 0.9 | 140,999 | Common Stock |
| Quince Therapeutics Inc | Dirk Thye | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.55 per share. | 16 Jan 2024 | 90,531 | 539,442 (1%) | 0% | 0.5 | 49,792 | Common Stock |
| Quince Therapeutics Inc | Thye Dirk | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 90,531 | 115,860 | - | - | Employee Stock Option (right to buy) | |
| Quince Therapeutics Inc | Dirk Thye | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 10 Aug 2023 | 88,000 | 448,911 (1%) | 0% | 1.3 | 110,880 | Common Stock |
| Quince Therapeutics Inc | Dirk Thye | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.24 per share. | 08 Aug 2023 | 80,000 | 360,911 (1%) | 0% | 1.2 | 99,200 | Common Stock |
| Quince Therapeutics Inc | Dirk Thye | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
| Quince Therapeutics Inc | Dirk Thye | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 216,322 | 280,911 (0%) | 0% | 0 | Common Stock |